InnerTrek Level 3 Offering:

Post FDA Approval
Comp360 Psilocybin Training

InnerTrek has been featured In

Compass Pathways is developing COMP360, an investigational psilocybin treatment.

InnerTrek is exploring potential training related to COMP360 care following FDA approval.

We have not yet determined what training InnerTrek may offer, who would be eligible, or when it might be available. However, these requirements are currently being defined and anticipated to be release in late 2026.